New Horizontal Merger Guidelines Indicate Greater Scrutiny of High Tech and Pharmaceutical Transactions
It also indicates greater Agency scrutiny of such transactions in industries characterized by differentiated products and high levels of R&D spendingâ€â€such as the high tech and pharmaceutical industries. Janet McDavid & Eric Stock (Hogan Lovells)